Since there is currently scanty information on the clinical variability associated with pathogenic POLR2A variants, further studies are required to explore the possibility of a differential clinical and functional impact of the different classes of these variants and their possible contribution to the predisposition to ependymomas inside the germline POLR2A neurodevelopmental disorder. This evidence concerns the gene POLR2A and neurodevelopmental disorder.